Skip to main content
Top
Published in: BMC Infectious Diseases 1/2011

Open Access 01-12-2011 | Research article

TREM-1 expression on neutrophils and monocytes of septic patients: relation to the underlying infection and the implicated pathogen

Authors: Thekla Poukoulidou, Aikaterini Spyridaki, Ira Mihailidou, Petros Kopterides, Aikaterini Pistiki, Zoi Alexiou, Michael Chrisofos, Ioanna Dimopoulou, Panagiotis Drimoussis, Evangelos J Giamarellos-Bourboulis, Ioannis Koutelidakis, Androniki Marioli, Anna Mega, Stylianos E Orfanos, Maria Theodorakopoulou, Christos Tsironis, Nina Maggina, Vlassios Polychronopoulos, Iraklis Tsangaris, the Hellenic Sepsis Study Group

Published in: BMC Infectious Diseases | Issue 1/2011

Login to get access

Abstract

Background

Current knowledge on the exact ligand causing expression of TREM-1 on neutrophils and monocytes is limited. The present study aimed at the role of underlying infection and of the causative pathogen in the expression of TREM-1 in sepsis.

Methods

Peripheral venous blood was sampled from 125 patients with sepsis and 88 with severe sepsis/septic shock. The causative pathogen was isolated in 91 patients. Patients were suffering from acute pyelonephritis, community-acquired pneumonia (CAP), intra-abdominal infections (IAIs), primary bacteremia and ventilator-associated pneumonia or hospital-acquired pneumonia (VAP/HAP). Blood monocytes and neutrophils were isolated. Flow cytometry was used to estimate the TREM-1 expression from septic patients.

Results

Within patients bearing intrabdominal infections, expression of TREM-1 was significantly lower on neutrophils and on monocytes at severe sepsis/shock than at sepsis. That was also the case for severe sepsis/shock developed in the field of VAP/HAP. Among patients who suffered infections by Gram-negative community-acquired pathogens or among patients who suffered polymicrobial infections, expression of TREM-1 on monocytes was significantly lower at the stage of severe sepsis/shock than at the stage of sepsis.

Conclusions

Decrease of the expression of TREM-1 on the membrane of monocytes and neutrophils upon transition from sepsis to severe sepsis/septic shock depends on the underlying type of infection and the causative pathogen.
Appendix
Available only for authorised users
Literature
1.
go back to reference Vincent JL, Sun Q, Dubois MJ: Clinical trials of immunomodulatory therapies in severe sepsis and septic shock. Clin Infect Dis. 2002, 34: 1084-1093. 10.1086/339549.CrossRefPubMed Vincent JL, Sun Q, Dubois MJ: Clinical trials of immunomodulatory therapies in severe sepsis and septic shock. Clin Infect Dis. 2002, 34: 1084-1093. 10.1086/339549.CrossRefPubMed
2.
go back to reference Gogos C, Kotsaki A, Pelekanou A, Giannikopoulos G, Vaki I, Maravitsa P, Adamis S, Alexiou Z, Andrianopoulos G, Antonopoulou A, Athanasia S, Baziaka F, Charalambous A, Christodoulou S, Dimopoulou I, Floros I, Giannitsioti E, Gkanas P, Ioakeimidou A, Kanellakopoulou K, Karabela N, Karagianni V, Katsarolis I, Kontopithari G, Kopterides P, Koutelidakis I, Koutoukas P, Kranidioti H, Lignos M, Louis K, et al: Early alterations of the innate and adaptive immune statuses in sepsis according to the type of underlying infection. Crit Care. 2010, 14: R96-10.1186/cc9031.CrossRefPubMedPubMedCentral Gogos C, Kotsaki A, Pelekanou A, Giannikopoulos G, Vaki I, Maravitsa P, Adamis S, Alexiou Z, Andrianopoulos G, Antonopoulou A, Athanasia S, Baziaka F, Charalambous A, Christodoulou S, Dimopoulou I, Floros I, Giannitsioti E, Gkanas P, Ioakeimidou A, Kanellakopoulou K, Karabela N, Karagianni V, Katsarolis I, Kontopithari G, Kopterides P, Koutelidakis I, Koutoukas P, Kranidioti H, Lignos M, Louis K, et al: Early alterations of the innate and adaptive immune statuses in sepsis according to the type of underlying infection. Crit Care. 2010, 14: R96-10.1186/cc9031.CrossRefPubMedPubMedCentral
3.
go back to reference Bouchon A, Facchetti F, Welgant MA, Colonna M: TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature. 2001, 410: 1103-1107. 10.1038/35074114.CrossRefPubMed Bouchon A, Facchetti F, Welgant MA, Colonna M: TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature. 2001, 410: 1103-1107. 10.1038/35074114.CrossRefPubMed
4.
go back to reference Colonna M, Facchetti F: TREM-1 (trigerring receptor expressed on myeloid cells): a new player in acute inflammatory responses. J Infect Dis. 2003, 187 (Suppl 2): 397-401.CrossRef Colonna M, Facchetti F: TREM-1 (trigerring receptor expressed on myeloid cells): a new player in acute inflammatory responses. J Infect Dis. 2003, 187 (Suppl 2): 397-401.CrossRef
6.
go back to reference Tessarz A, Cerwenka A: The TREM-1/DAP12 pathway. Immunoogy Letters. 2008, 116: 111-116. 10.1016/j.imlet.2007.11.021.CrossRef Tessarz A, Cerwenka A: The TREM-1/DAP12 pathway. Immunoogy Letters. 2008, 116: 111-116. 10.1016/j.imlet.2007.11.021.CrossRef
7.
go back to reference Sharif O, Knapp S: From expression to signaling: Roles of TREM-1 and TREM-2 in innate immunity and bacterial infection. Immunology. 2008, 213: 701-713. Sharif O, Knapp S: From expression to signaling: Roles of TREM-1 and TREM-2 in innate immunity and bacterial infection. Immunology. 2008, 213: 701-713.
8.
go back to reference Klesney-Tait J, Turnbull IR, Cilonna M: The TREM receptor family and signal integration. Nat Immunol. 2006, 7: 1266-1273. 10.1038/ni1411.CrossRefPubMed Klesney-Tait J, Turnbull IR, Cilonna M: The TREM receptor family and signal integration. Nat Immunol. 2006, 7: 1266-1273. 10.1038/ni1411.CrossRefPubMed
9.
go back to reference Radsak MP, Salih HR, Rammensee HR, Schild H: Triggering receptor expressed on myeloid cells-1 in neutrophil inflammatory responses: differential regulation of activation and survival. J Immunol. 2004, 172: 4956-4963.CrossRefPubMed Radsak MP, Salih HR, Rammensee HR, Schild H: Triggering receptor expressed on myeloid cells-1 in neutrophil inflammatory responses: differential regulation of activation and survival. J Immunol. 2004, 172: 4956-4963.CrossRefPubMed
10.
go back to reference Giamarellos-Bourboulis EJ, Tsangaris I, Kanni Th, Mouktaroudi M, Pantelidou I, Adamis G, Atmatzidis S, Chrisofos M, Evangelopoulou V, Frantzeskaki F, et al: Procalcitonin as an early indicator of outcome in sepsis: a prospective observational study. J Hosp Infect. 2011, 77: 58-63. 10.1016/j.jhin.2010.07.026.CrossRefPubMed Giamarellos-Bourboulis EJ, Tsangaris I, Kanni Th, Mouktaroudi M, Pantelidou I, Adamis G, Atmatzidis S, Chrisofos M, Evangelopoulou V, Frantzeskaki F, et al: Procalcitonin as an early indicator of outcome in sepsis: a prospective observational study. J Hosp Infect. 2011, 77: 58-63. 10.1016/j.jhin.2010.07.026.CrossRefPubMed
11.
go back to reference Georgopoulou AP, Savva A, Giamarellos-Bourboulis EJ, Georgitsi M, Raftogiannis M, Antonakos N, et al: Early changes of procalcitonin may advise about prognosis and appropriateness of antimicrobial therapy in sepsis. J Crit Care. 2011, 26: 331.e1-331.e7.CrossRef Georgopoulou AP, Savva A, Giamarellos-Bourboulis EJ, Georgitsi M, Raftogiannis M, Antonakos N, et al: Early changes of procalcitonin may advise about prognosis and appropriateness of antimicrobial therapy in sepsis. J Crit Care. 2011, 26: 331.e1-331.e7.CrossRef
12.
go back to reference Levy M, Fink M, Marshall J, Abraham E, Angus D, Cook D, Cohen J, Opal S, Vincent J, Ramsay G, SCCM/ESICM/ACCP/ATS/SIS: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definition conference. Crit Care Med. 2003, 31: 1250-1256. 10.1097/01.CCM.0000050454.01978.3B.CrossRefPubMed Levy M, Fink M, Marshall J, Abraham E, Angus D, Cook D, Cohen J, Opal S, Vincent J, Ramsay G, SCCM/ESICM/ACCP/ATS/SIS: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definition conference. Crit Care Med. 2003, 31: 1250-1256. 10.1097/01.CCM.0000050454.01978.3B.CrossRefPubMed
13.
go back to reference Christ-Crain M, Stolz D, Bingisser R, Müller C, Miedinger D, Huber PR, Zimmerli W, Harbath S, Tamm M, Müller B: Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia. A randomized trial. Am J Resp Crit Care Med. 2006, 174: 84-93. 10.1164/rccm.200512-1922OC.CrossRefPubMed Christ-Crain M, Stolz D, Bingisser R, Müller C, Miedinger D, Huber PR, Zimmerli W, Harbath S, Tamm M, Müller B: Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia. A randomized trial. Am J Resp Crit Care Med. 2006, 174: 84-93. 10.1164/rccm.200512-1922OC.CrossRefPubMed
14.
go back to reference Chastre J, Fagon JY: Ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002, 165: 867-903.CrossRefPubMed Chastre J, Fagon JY: Ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002, 165: 867-903.CrossRefPubMed
15.
go back to reference Vincent JL: Ventilator-associated pneumonia. J Hosp Infect. 2004, 57: 272-280. 10.1016/j.jhin.2003.06.001.CrossRefPubMed Vincent JL: Ventilator-associated pneumonia. J Hosp Infect. 2004, 57: 272-280. 10.1016/j.jhin.2003.06.001.CrossRefPubMed
16.
go back to reference Pinson AG, Philbrick JT, Lindbeck GH, Schorling JB: Fever in the clinical diagnosis of acute pyelonephritis. Am J Emerg Med. 1997, 15: 148-151. 10.1016/S0735-6757(97)90087-5.CrossRefPubMed Pinson AG, Philbrick JT, Lindbeck GH, Schorling JB: Fever in the clinical diagnosis of acute pyelonephritis. Am J Emerg Med. 1997, 15: 148-151. 10.1016/S0735-6757(97)90087-5.CrossRefPubMed
17.
go back to reference Calandra T, Cohen J: The international Sepsis Forum Consensus definitions of infections in the intensive care unit. Crit Care Med. 2005, 33: 1639-48.CrossRef Calandra T, Cohen J: The international Sepsis Forum Consensus definitions of infections in the intensive care unit. Crit Care Med. 2005, 33: 1639-48.CrossRef
18.
go back to reference Vincent JL: Clinical sepsis and septic shock definition, diagnosis and management principles. Langenbecks Arch Surg. 2008, 393: 817-824. 10.1007/s00423-008-0343-1.CrossRefPubMed Vincent JL: Clinical sepsis and septic shock definition, diagnosis and management principles. Langenbecks Arch Surg. 2008, 393: 817-824. 10.1007/s00423-008-0343-1.CrossRefPubMed
20.
go back to reference Bouchon A, Dietrich J, Colonna M: Cutting edge. Inflammatory responses can be trigerred by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol. 2000, 164: 4991-4995.CrossRefPubMed Bouchon A, Dietrich J, Colonna M: Cutting edge. Inflammatory responses can be trigerred by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol. 2000, 164: 4991-4995.CrossRefPubMed
21.
go back to reference Gibot S, Le Renard PE, Bollaert PE, Kolopp-Sarda MN, Bene MC, Faure GC, Levy B: Surface trigerring receptor expressed on myeloid cells 1 expression patterns in septic shock. Intensive Care Med. 2005, 31: 594-597. 10.1007/s00134-005-2572-x.CrossRefPubMed Gibot S, Le Renard PE, Bollaert PE, Kolopp-Sarda MN, Bene MC, Faure GC, Levy B: Surface trigerring receptor expressed on myeloid cells 1 expression patterns in septic shock. Intensive Care Med. 2005, 31: 594-597. 10.1007/s00134-005-2572-x.CrossRefPubMed
22.
go back to reference Dimopoulou I, Orfanos SE, Pelekanou A, Kotanidou A, Livaditi O, Augustatou C, Zervou M, Douka E, Theodorakopoulou M, Karagianni V, Douzinas E, Armaganidis A, Giamarellos-Bourboulis EJ: Serum of patients with septic shock stimulates the expression of TREM-1 on U937 monocytes. Inflamm Res. 2009, 58: 127-132. 10.1007/s00011-008-7039-4.CrossRefPubMed Dimopoulou I, Orfanos SE, Pelekanou A, Kotanidou A, Livaditi O, Augustatou C, Zervou M, Douka E, Theodorakopoulou M, Karagianni V, Douzinas E, Armaganidis A, Giamarellos-Bourboulis EJ: Serum of patients with septic shock stimulates the expression of TREM-1 on U937 monocytes. Inflamm Res. 2009, 58: 127-132. 10.1007/s00011-008-7039-4.CrossRefPubMed
23.
go back to reference Gibot S, Kolopp-Sarda MN, Béné MC, Cravoisy A, Levy B, Faure GC, Bollaert PE: Plasma level of a trigerring receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis. Ann Intern Med. 2004, 141: 9-15.CrossRefPubMed Gibot S, Kolopp-Sarda MN, Béné MC, Cravoisy A, Levy B, Faure GC, Bollaert PE: Plasma level of a trigerring receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis. Ann Intern Med. 2004, 141: 9-15.CrossRefPubMed
24.
go back to reference Barati M, Bashar FR, Shahrami R, Zadeh MH, Taher MT, Nojomi M: Soluble triggering receptor expressed on myeloid cells 1 and the diagnosis of sepsis. J Crit Care. 2010, 25: 362.e1-e6. 10.1016/j.jcrc.2009.10.004.CrossRef Barati M, Bashar FR, Shahrami R, Zadeh MH, Taher MT, Nojomi M: Soluble triggering receptor expressed on myeloid cells 1 and the diagnosis of sepsis. J Crit Care. 2010, 25: 362.e1-e6. 10.1016/j.jcrc.2009.10.004.CrossRef
25.
go back to reference Barraud D, Gibot S: Triggering receptor expressed on myeloid cells 1. Crit Care Clin. 2011, 27: 265-279. 10.1016/j.ccc.2010.12.006.CrossRefPubMed Barraud D, Gibot S: Triggering receptor expressed on myeloid cells 1. Crit Care Clin. 2011, 27: 265-279. 10.1016/j.ccc.2010.12.006.CrossRefPubMed
26.
go back to reference Porfiridis I, Plachouras D, Karagianni V, Kotanidou A, Papiris S, Giamarellou H, Giamarellos-Bourboulis EJ: Diagnostic value of triggering receptor expressed on myeloid cells-1 and C-reactive protein for patients with lung infiltrates: an observational study. BMC Infectious Diseases. 2010, 10: 286-10.1186/1471-2334-10-286.CrossRef Porfiridis I, Plachouras D, Karagianni V, Kotanidou A, Papiris S, Giamarellou H, Giamarellos-Bourboulis EJ: Diagnostic value of triggering receptor expressed on myeloid cells-1 and C-reactive protein for patients with lung infiltrates: an observational study. BMC Infectious Diseases. 2010, 10: 286-10.1186/1471-2334-10-286.CrossRef
27.
go back to reference Pelekanou A, Tsangaris I, Kotsaki A, Karagianni V, Giamarellou H, Armaganidis A, Giamarellos-Bourboulis EJ: Decrease of CD4-lymphocytes and apoptosis of CD14-monocytes are characteristic alterations in sepsis caused by ventilator-associated pneumonia: results from an observational study. Crit Care. 2009, 13: R172-10.1186/cc8148.CrossRefPubMedPubMedCentral Pelekanou A, Tsangaris I, Kotsaki A, Karagianni V, Giamarellou H, Armaganidis A, Giamarellos-Bourboulis EJ: Decrease of CD4-lymphocytes and apoptosis of CD14-monocytes are characteristic alterations in sepsis caused by ventilator-associated pneumonia: results from an observational study. Crit Care. 2009, 13: R172-10.1186/cc8148.CrossRefPubMedPubMedCentral
28.
go back to reference Giamarelos-Bourboulis EJ, Zakynthinos S, Baziaka F, Papadomichelakis E, Virtzili S, Koutoukas P, Armaganidis A, Giamarellou H, Roussos C: Soluble trigerring receptor expressed on myeloid cells-1 as an anti-inflammatory mediator in sepsis. Intensive Care Med. 2006, 32: 237-243. 10.1007/s00134-005-0017-1.CrossRef Giamarelos-Bourboulis EJ, Zakynthinos S, Baziaka F, Papadomichelakis E, Virtzili S, Koutoukas P, Armaganidis A, Giamarellou H, Roussos C: Soluble trigerring receptor expressed on myeloid cells-1 as an anti-inflammatory mediator in sepsis. Intensive Care Med. 2006, 32: 237-243. 10.1007/s00134-005-0017-1.CrossRef
Metadata
Title
TREM-1 expression on neutrophils and monocytes of septic patients: relation to the underlying infection and the implicated pathogen
Authors
Thekla Poukoulidou
Aikaterini Spyridaki
Ira Mihailidou
Petros Kopterides
Aikaterini Pistiki
Zoi Alexiou
Michael Chrisofos
Ioanna Dimopoulou
Panagiotis Drimoussis
Evangelos J Giamarellos-Bourboulis
Ioannis Koutelidakis
Androniki Marioli
Anna Mega
Stylianos E Orfanos
Maria Theodorakopoulou
Christos Tsironis
Nina Maggina
Vlassios Polychronopoulos
Iraklis Tsangaris
the Hellenic Sepsis Study Group
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2011
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-11-309

Other articles of this Issue 1/2011

BMC Infectious Diseases 1/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.